Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引：7
|
作者：
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构：
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
来源：
THORAX | 2013年 / 68卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I：
10.1136/thoraxjnl-2012-202483
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [31] Step up to ICS/LAMA/LABA vs switch to LAMA/LABA in patients with COPD on ICS/LABA: post hoc analysis of KRONOS
    Singh, Dave
    Bafadhel, Mona
    Bowen, Karin
    Arya, Niki
    Marshall, Jonathan
    Parikh, Himanshu
    Patel, Mehul
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [32] Comparison of the Effects of Conventional Fixed ICS/LABA Combined Therapy Versus Combined Maintenance and Reliever ICS/Formoterol Therapy on the Treatment of Adherence and Inhaler Satisfaction of Asthma Patients Who Received Inhaler Education
    Gemicioglu, B.
    Sekibag, Y.
    Borekci, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [33] THE COST-EFFECTIVENESS OF STEP DOWN FROM HIGH DOSE ICS/LABA COMBINATION THERAPY IN ASTHMA IN THE UK SETTING
    Paggiaro, P.
    Buseghin, G.
    Nicolini, G.
    Patel, S.
    Iannazzo, S.
    Zaniolo, O.
    Papi, A.
    VALUE IN HEALTH, 2011, 14 (07) : A493 - A494
  • [34] Adding a LAMA to ICS/LABA Therapy A Meta-analysis of Triple Combination Therapy in COPD
    Calzetta, Luigino
    Cazzola, Mario
    Matera, Maria Gabriella
    Rogliani, Paola
    CHEST, 2019, 155 (04) : 758 - 770
  • [35] CAPTAIN: EFFECTS OF BASELINE SABA USE ON RESPONSE TO TRIPLE THERAPY IN PATIENTS WITH INADEQUATELY CONTROLLED ASTHMA ON ICS/LABA
    Busse, William
    Abbott, Carl
    Chang, Sarah
    Casale, Thomas
    Zarankaite, Agne
    Caceres, Diego Maselli
    CHEST, 2021, 160 (04) : 2357A - 2358A
  • [36] CURRENT PATTERNS OF FIXED AND FREE LABA/ICS COMBINATION USAGE IN ASTHMA SHI PATIENTS IN GERMANY
    Bonthapally, V
    Wolbring, F.
    Sindern, J.
    Mehnert, A.
    VALUE IN HEALTH, 2009, 12 (03) : A128 - A128
  • [37] Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention
    Aalbers, Rene
    Vogelmeier, Claus
    Kuna, Piotr
    RESPIRATORY MEDICINE, 2016, 111 : 1 - 7
  • [38] Extrafine triple therapy shows improved efficacy compared to ICS/LABA in a mouse model of asthma
    Miglietta, D.
    Pisano, A. R.
    Allen, A.
    Fragni, D.
    Federico, G.
    Bignami, F.
    Zambelli, E.
    Zecchi, R.
    Boscaro, F.
    Pioselli, B.
    Mileo, V.
    Civelli, M.
    Villetti, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment
    Kerwin, Edward
    Dorinsky, Paul
    Patel, Mehul
    Rossman, Kimberly
    Reisner, Colin
    Maes, Andrea
    Darken, Patrick
    Griffis, Dianne
    Fjallbrant, Harald
    JOURNAL OF ASTHMA, 2022, 59 (07) : 1420 - 1432
  • [40] ASSESSING ALGORITHMS TO IDENTIFY ASTHMA PATIENTS USING MULTIPLE INHALER TRIPLE THERAPY (COMPRISING ICS, LABA, LAMA) IN A REAL-WORLD DATABASE
    Meeraus, W.
    Numbere, B.
    Liu, Y.
    Czira, A.
    Zhang, W.
    VALUE IN HEALTH, 2022, 25 (01) : S271 - S271
12345